BDNF-mediated cerebellar granule cell development is impaired in mice null for CaMKK2 or CaMKIV - PubMed (original) (raw)
BDNF-mediated cerebellar granule cell development is impaired in mice null for CaMKK2 or CaMKIV
Manabu Kokubo et al. J Neurosci. 2009.
Abstract
The Ca(2+)/calmodulin-activated kinases CaMKK2 and CaMKIV are highly expressed in the brain where they play important roles in activating intracellular responses to elevated Ca(2+). To address the biological functions of Ca(2+) signaling via these kinases during brain development, we have examined cerebellar development in mice null for CaMKK2 or CaMKIV. Here, we demonstrate that CaMKK2/CaMKIV-dependent phosphorylation of cAMP response element-binding protein (CREB) correlates with Bdnf transcription, which is required for normal development of cerebellar granule cell neurons. We show in vivo and in vitro that the absence of either CaMKK2 or CaMKIV disrupts the ability of developing cerebellar granule cells in the external granule cell layer to cease proliferation and begin migration to the internal granule cell layer. Furthermore, loss of CaMKK2 or CaMKIV results in decreased CREB phosphorylation (pCREB), Bdnf exon I and IV-containing mRNAs, and brain-derived neurotrophic factor (BDNF) protein in cerebellar granule cell neurons. Reexpression of CaMKK2 or CaMKIV in granule cells that lack CaMKK2 or CaMKIV, respectively, restores pCREB and BDNF to wild-type levels and addition of BDNF rescues granule cell migration in vitro. These results reveal a previously undefined role for a CaMKK2/CaMKIV cascade involved in cerebellar granule cell development and show specifically that Ca(2+)-dependent regulation of BDNF through CaMKK2/CaMKIV is required for this process.
Figures
Figure 1.
Planimetric analysis of the cerebellum from adult WT, _Camk4_−/−, and _Camkk2_−/− mice. A, Mid-sagittal cerebellar sections from 3-month-old WT, _Camk4_−/−, and _Camkk2_−/− mice were stained with cresyl violet and photographed at 1× magnification. Shown are representative cerebellar sections (scale bars, 1 mm). B, The percentage of the IGL cross-sectional area compared with the whole cerebellum was quantified as described in Materials and Methods. The percentage of the cerebellar cross-sectional area relegated to the IGL was decreased from 44.3% in the wild-type to 38.4% in the _Camk4_−/− and 37.5% in the _Camkk2_−/− mice. Values shown are mean ± SEM (*p < 0.01 for difference against WT; n = 5 for each genotype). C, Three-month-old _Camk4_−/− and _Camkk2_−/− mice show no difference in IGL cell density compared with WT (values shown are mean ± SEM; n = 5 for each genotype).
Figure 2.
Structural analysis of the cerebellum from postnatal 7-d-old WT, _Camk4_−/−, and _Camkk2_−/− mice. A, Mid-sagittal sections from P7 WT, _Camk4_−/−, and _Camkk2_−/− mice were stained with cresyl violet and photographed at 1× magnification. Shown are representative cerebellar sections (scale bars, 1 mm). B, Representative sections of cerebella derived from P7 WT, _Camk4_−/−, and _Camkk2_−/− mice. Shown at 20× magnification is the mid-portion of the fifth folia. Note the abnormally thicker EGL in both _Camk4_−/− and _Camkk2_−/− mice (scale bars, 100 μm). C, The percentage of the EGL cross-sectional area compared with the whole cerebellum was quantified as described in Materials and Methods. The percentage of the cerebellar cross-sectional area relegated to the EGL was increased from 13.4% in the WT to 18.4% in the _Camk4_−/− and 18.6% in the _Camkk2_−/− mice. Values shown are mean ± SEM (*p < 0.01 for difference against WT; n = 5 for each genotype). D, Planimetric measurement of the EGL width shows a significant increase in the _Camk4_−/− and _Camkk2_−/− mice compared with WT. Values shown are mean ± SEM (*p < 0.05 for difference against WT; n = 5 for each genotype). E, Seven-day-old _Camk4_−/− and _Camkk2_−/− mice show no difference in EGL cell density compared with WT (values shown are mean ± SEM; n = 5 for each genotype).
Figure 3.
_Camk4_−/− and _Camkk2_−/− mice have increased cell proliferation and apoptosis in the EGL at postnatal day 7. A, Representative photograph showing the identification of proliferating cells after immunolabeling against the Ki-67 nuclear antigen. Note the relative increase in cells staining positive in the sections from both the _Camk4_−/− and _Camkk2_−/− mice (scale bars, 100 μm). B, The left panel shows the quantification of the total percentage of Ki-67-positive cells in the EGL area. The right panel shows that there was no difference in the average staining intensity of the cells, thus confirming the increase in proliferating cells from both null mice. Values shown are mean ± SEM (*p < 0.05 for difference against WT; p = 0.3 for difference in staining intensity; n = 4 for each genotype). C, The top is a representative photograph of apoptotic GCPs in wild-type, _Camk4_−/−, and _Camkk2_−/− mice identified by Tunnel staining (scale bars, 50 μm). The bottom is a higher magnification to demonstrate that the nuclei are indeed positively stained. D, Quantification showing an increase in the number of TUNEL-positive cells per square millimeter in the EGL of _Camk4_−/− and _Camkk2_−/− mice compared with WT. Values shown are mean ± SEM (*p < 0.01 for difference against WT; n = 4 for each genotype).
Figure 4.
In vivo analysis of migrating granule cells. A, Proliferating GCPs in P7 WT, _Camk4_−/−, and _Camkk2_−/− mice were labeled by systemic injection of 50 mg/kg BrdU. Cerebella were then collected and processed for BrdU immunohistochemistry at 24 and 48 h after injection. DAPI stain (data not shown) was used to aid in identification of each cellular layer (scale bar, 50 μm). B, Quantification of BrdU-labeled GCPs at 48 h within the three layers of the developing cerebellum. The number of labeled cells in each layer of the cerebellum (EGL, ML, and IGL) was counted in nonadjacent mid-sagittal sections and averaged. Both _Camk4_−/− and _Camkk2_−/− mice have a significant increase in the number of BrdU-labeled cells which have not migrated out of the EGL and a significant decrease in the number of cells which have migrated to the ML and IGL. Values shown are mean ± SEM (*p < 0.05 for difference against WT; n = 4 mice from each genotype).
Figure 5.
In vitro analysis of wild-type, _Camk4_−/−, and _Camkk2_−/− cerebella using micro-explants. A, Cerebellar micro-explants derived from P3 mice were cultured in vitro. The top panel shows representative micro-explants from the three genotypes and reveal a reduction in the ability of GCPs from the _Camk4_−/− and _Camkk2_−/− micro-explants to migrate as far as those from wild type (zone1 = 0–100 μm; zone 2 = 100–200 μm; zone 3 = 200 μm and beyond). The bottom panel shows a representative set of micro-explants where conditioned medium removed from WT micro-explants was used instead of fresh media in the cultures of _Camk4_−/− and _Camkk2_−/− micro-explants. Use of the conditioned medium partially rescues the migration defect (scale bars, 200 μm). B, Quantification of the number of GCPs which have migrated to specified distances (zone1 = 0–100 μm; zone 2 = 100–200 μm; zone 3 = 200 μm and beyond). There is a significant reduction in the number of GCPs from both null micro-explants that migrate further than 100 μm in fresh medium. Addition of the conditioned medium to both null micro-explants significantly improves cellular migration compared with the null micro-explants that received fresh medium. This conditioned medium, however, only partially restores the ability of cells from either null micro-explant to migrate as far as does the WT cells. C, Representative set of micro-explants where conditioned medium removed from _Camk4_−/− and _Camkk2_−/− micro-explants and placed on cultures of _Camkk2_−/− and _Camk4_−/− micro-explants, respectively. D, Quantification showing that conditioned medium from _Camk4_−/− micro-explants does not rescue _Camkk2_−/− micro-explants and vice versa. Values shown are mean ± SEM (*p < 0.01 for nonconditioned and conditioned medium difference against WT; **p < 0.05 for _Camk4_−/− and _Camkk2_−/− conditioned medium difference against _Camk4_−/− and _Camkk2_−/− nonconditioned medium; n = 4 for each genotype).
Figure 6.
Addition of exogenous BDNF to cerebellar micro-explants restores GCP migration. A, The top panel shows representative micro-explants from the three genotypes again revealing a reduction in the ability of GCPs from the _Camk4_−/− and _Camkk2_−/− micro-explants to migrate as far as those from WT (zone1 = 0–100 μm; zone 2 = 100–200 μm; zone 3 = 200 μm and beyond). The addition of exogenous BDNF (middle panel) rescues both null explants by restoring migration of GCPs to levels seen in WT, which did not received exogenous BDNF. Addition of TrkB-Fc blocks the migration of WT explants and mirrors migration of that seen in both the _Camk4_−/− and _Camkk2_−/− micro-explants (scale bars, 200 μm). B, Quantification of the number of GCPs which have migrated to specified distances (zone1 = 0–100 μm; zone 2 = 100–200 μm; zone 3 = 200 μm and beyond). As demonstrated in the previous figure, there is a significant reduction in the number of GCPs from both null micro-explants that migrate further than 100 μm in basal media. Addition of the media containing BDNF (100 ng/ml) to both null micro-explants significantly improves migration to normal levels seen in WT micro-explants, which did not receive exogenous BDNF. The addition of exogenous BDNF also results in an increase in migrating cells in the WT micro-explant. Addition of TrkB-Fc inhibits BDNF mediated migration in WT micro-explants. Values shown are mean ± SEM (*p < 0.01 for difference against WT; **p < 0.01 for difference of _Camk4_−/− and _Camkk2_−/− + BDNF vs _Camk4_−/− and _Camkk2_−/−, #p < 0.05, ##p < 0.01 for difference of WT + BDNF against WT and +p < 0.01 for difference of WT + TrkB-Fc against WT; n = 4 for each experimental genotype).
Figure 7.
BDNF protein and mRNA are reduced in both _Camk4_−/− and _Camkk2_−/− mice. A, ELISA quantification of BDNF in freshly isolated GCP extracts. Values shown are mean ± SEM (*p < 0.01 for difference against WT; n = 6 for each genotype). B, Real-time PCR analysis of total Bdnf mRNA in freshly isolated GCPs. Values shown are mean ± SEM (*p < 0.05 for difference against WT; n = 7 for each genotype). C, Real-time PCR analysis of Bdnf mRNA in freshly isolated GCPs using specific primers to detect transcripts derived from either exon I or exon IV. Values shown are mean ± SEM (*p < 0.01 for difference against WT; n = 7 for each genotype).
Figure 8.
Lentiviral-mediated reexpression of CaMKIV or CaMKK2 restores pCREB and BDNF. A, Representative immunoblot of protein extracts derived from cultured WT and _Camk4_−/− GCPs or _Camk4_−/− GCPs which have been left uninfected, infected with either a lentiviral-CaMKIV-WT (active) or lentiviral-CaMKIV-K71M (inactive) construct. Note lower level of BDNF and pCREB in _Camk4_−/− GCPs. The reexpression of a catalytically active form of CaMKIV restored both BDNF and pCREB levels, whereas expression of the catalytically inactive CaMKIV-K71M did not restore BDNF or pCREB levels. B, Quantification of immunoblots after normalizing to total CREB (values shown are mean ± SEM; *p < 0.01 for difference against WT; n = 4 independent experiments). C, Representative Western blot analysis of protein extracts derived from cultured WT and _Camkk2_−/− GCPs or _Camkk2_−/− GCPs, which have been left uninfected or infected with either a lentiviral-CaMKK2-WT (active) or lentiviral-CaMKK2-K193E (inactive) construct. The lower molecular weight band seen so prominently in the _Camkk2_−/− lane is CaMKK1. Note that there is also reduced BDNF and pCREB protein in _Camkk2_−/− GCPs. The reexpression of a catalytically active form of CaMKK2 also restored both BDNF and pCREB levels, whereas expression of the catalytically inactive CaMKK2-K193E did not restore BDNF or pCREB levels. B, Quantification of immunoblots after normalizing to total CREB (values shown are the mean ± SEM; *p < 0.05 for difference against WT; n = 3 independent experiments).
Similar articles
- The camKK2/camKIV relay is an essential regulator of hepatic cancer.
Lin F, Marcelo KL, Rajapakshe K, Coarfa C, Dean A, Wilganowski N, Robinson H, Sevick E, Bissig KD, Goldie LC, Means AR, York B. Lin F, et al. Hepatology. 2015 Aug;62(2):505-20. doi: 10.1002/hep.27832. Epub 2015 May 9. Hepatology. 2015. PMID: 25847065 Free PMC article. - Nicotine Rescues Depressive-like Behaviors via α7-type Nicotinic Acetylcholine Receptor Activation in CaMKIV Null Mice.
Moriguchi S, Inagaki R, Yi L, Shibata M, Sakagami H, Fukunaga K. Moriguchi S, et al. Mol Neurobiol. 2020 Dec;57(12):4929-4940. doi: 10.1007/s12035-020-02077-z. Epub 2020 Aug 19. Mol Neurobiol. 2020. PMID: 32815115 - Stimulation of Sigma-1 Receptor Ameliorates Depressive-like Behaviors in CaMKIV Null Mice.
Moriguchi S, Sakagami H, Yabuki Y, Sasaki Y, Izumi H, Zhang C, Han F, Fukunaga K. Moriguchi S, et al. Mol Neurobiol. 2015 Dec;52(3):1210-1222. doi: 10.1007/s12035-014-8923-2. Epub 2014 Oct 15. Mol Neurobiol. 2015. PMID: 25316382 - Regulation and properties of the rat Ca2+/calmodulin-dependent protein kinase IV gene and its protein products.
Means AR, Ribar TJ, Kane CD, Hook SS, Anderson KA. Means AR, et al. Recent Prog Horm Res. 1997;52:389-406; discussion 406-7. Recent Prog Horm Res. 1997. PMID: 9238860 Review. - The Ca(2+)/Calmodulin/CaMKK2 Axis: Nature's Metabolic CaMshaft.
Marcelo KL, Means AR, York B. Marcelo KL, et al. Trends Endocrinol Metab. 2016 Oct;27(10):706-718. doi: 10.1016/j.tem.2016.06.001. Epub 2016 Jul 20. Trends Endocrinol Metab. 2016. PMID: 27449752 Free PMC article. Review.
Cited by
- CaMKK2 as an emerging treatment target for bipolar disorder.
Kaiser J, Nay K, Horne CR, McAloon LM, Fuller OK, Muller AG, Whyte DG, Means AR, Walder K, Berk M, Hannan AJ, Murphy JM, Febbraio MA, Gundlach AL, Scott JW. Kaiser J, et al. Mol Psychiatry. 2023 Nov;28(11):4500-4511. doi: 10.1038/s41380-023-02260-3. Epub 2023 Sep 20. Mol Psychiatry. 2023. PMID: 37730845 Free PMC article. Review. - Building better brains: the pleiotropic function of neurotrophic factors in postnatal cerebellar development.
Boxy P, Nykjær A, Kisiswa L. Boxy P, et al. Front Mol Neurosci. 2023 May 12;16:1181397. doi: 10.3389/fnmol.2023.1181397. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37251644 Free PMC article. Review. - Expression in skin biopsies supports genetic evidence linking CAMKK2, P2X7R and P2X4R with HIV-associated sensory neuropathy.
Gaff J, Octaviana F, Jackaman C, Kamerman P, Papadimitriou J, Lee S, Mountford J, Price P. Gaff J, et al. J Neurovirol. 2023 Jun;29(3):241-251. doi: 10.1007/s13365-023-01134-2. Epub 2023 May 11. J Neurovirol. 2023. PMID: 37166584 Free PMC article. - Fibroblast exosomal TFAP2C induced by chitosan oligosaccharides promotes peripheral axon regeneration via the miR-132-5p/CAMKK1 axis.
Zhao Y, Liu J, Liu S, Yang P, Liang Y, Ma J, Mao S, Sun C, Yang Y. Zhao Y, et al. Bioact Mater. 2023 Mar 9;26:249-263. doi: 10.1016/j.bioactmat.2023.03.002. eCollection 2023 Aug. Bioact Mater. 2023. PMID: 36936807 Free PMC article. - Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma.
Tomaszewski WH, Waibl-Polania J, Chakraborty M, Perera J, Ratiu J, Miggelbrink A, McDonnell DP, Khasraw M, Ashley DM, Fecci PE, Racioppi L, Sanchez-Perez L, Gunn MD, Sampson JH. Tomaszewski WH, et al. Nat Commun. 2022 Oct 29;13(1):6483. doi: 10.1038/s41467-022-34175-y. Nat Commun. 2022. PMID: 36309495 Free PMC article.
References
- Altman J, Bayer SA. Development of the cerebellar system: in relation to its evolution, structure and functions. Boca Raton, FL: CRC; 1997.
- Anderson KA, Ribar TJ, Lin F, Noeldner PK, Green MF, Muehlbauer MJ, Witters LA, Kemp BE, Means AR. Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metab. 2008;7:377–388. - PubMed
- Borghesani PR, Peyrin JM, Klein R, Rubin J, Carter AR, Schwartz PM, Luster A, Corfas G, Segal RA. BDNF stimulates migration of cerebellar granule cells. Development. 2002;129:1435–1442. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous